SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD FEB 05
MCX SILVER MAR 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD FEB 05
MCX SILVER MAR 05
MCX CRUDEOIL FEB 19
MCX NATURALGAS FEB 23
USD/INR
EUR/INR
GBP/INR
JPY/INR

Stock Market Live: Sensex tumbles 500 points, Nifty below 14,100; banks, financial stocks drag most

Global green bond issuance hit new record high last year

Oil prices steady as lockdowns curb US stimulus optimism

Will dollar-rupee pair break 72.50-mark?

Auto

Centrum Broking: Good time to book profits in auto; Auro, Sun and DRL top picks in pharma

Updated : January 14, 2021 10:35 AM IST

People are expecting the strong recovery to continue that has been seen in the current quarter in the auto sector, said Nischal Maheshwari, CEO-Institutional Equities and Advisory at Centrum Broking on Thursday.

“We have to wait to see whether these numbers still translate itself basically into what we have seen in the last two-three months especially on the four-wheelers and also on the commercial vehicle (CV) cycle,” he said.

Maheshwari believes this could be a good time to book profits in some of the auto stocks.

“Especially on the CV, both Ashok Leyland and Tata Motors seem to be running ahead of the expectations. Two-wheelers seem to be leaving some scope for upward bias, Maruti seems to be ahead of its numbers. So I think this could be a good time to take away some profits on the auto stocks.”

On the public sector undertaking (PSU) side, there is some amount of optimism. Maheshwari considers PSU banks as good trading stocks except for a few.

“Possibly PSU banks will also do better than what is right now being put out by the Reserve Bank of India (RBI). So valuation and more optimism on the recovery in the economy is what is making people buy some PSU banks.”

There are more legs as far as the pharmaceutical sector is concerned, he said.

“Larger companies which have got a spread across generic and formulations, I definitely see more legs to growth, not only domestically but also internationally. So our top picks continue to remain Aurobindo Pharma, Sun Pharmaceuticals and Dr Reddy’s Laboratories (DRL) in that order,” Maheshwari said.

Watch the video for more

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

You May Also Like

Coronavirus News LIVE Updates: 12,689 fresh COVID-19 cases take India's infection tally to 1,06,89,527

Coronavirus News LIVE Updates: 12,689 fresh COVID-19 cases take India's infection tally to 1,06,89,527

Closing Bell: Sensex ends 531 points lower, Nifty down 1%; RIL falls over 5% post Q3

Closing Bell: Sensex ends 531 points lower, Nifty down 1%; RIL falls over 5% post Q3

Coronavirus Latest Updates: 9,102 new COVID-19 cases in India, 117 more deaths; active cases at 1,77,266

Coronavirus Latest Updates: 9,102 new COVID-19 cases in India, 117 more deaths; active cases at 1,77,266

Trending on CNBC-TV18

Live TV

recommended for you